Company page

Atricure, Inc.

Atricure, Inc. is a public company listed under the ticker ATRC, operating in the American market. The company has a market capitalization of approximately $1.46 billion. Atricure focuses on developing innovative medical devices for the treatment of atrial fibrillation and other cardiac conditions.